Corona del Mar, California – Integrated Oncology Network, LLC (“ION”) today announced that it has launched its business. ION provides oncology solutions for physician practices and hospitals that need strategic, financial and management expertise. ION has expertise and provides solutions for:
- Transactional Services (buy-side, sell-side and FMV analysis)
- Project Development for Cancer Centers
- Financing – Debt & Equity Solutions
- Management Services – Accounting, IT, Compliance, M&A, Operations, B&C and Physics and Dosimetry
“We believe that ION is well positioned to offer unique solutions in today’s marketplace with many challenges, and we are excited by the opportunities,” said Grant Ingersoll, Managing Director of ION.
Jeffrey Goffman, Chairman of the ION Board of Directors, stated, “We are excited about the opportunity to launch ION with all of our resources and relationships. We believe that our successful historical operating strategies will leap-frog us into the forefront of alternative solutions for oncology partners.”
[eltdf_separator class_name=”” type=”full-width” position=”center” color=”#666666″ border_style=”dashed” width=”” thickness=”1″ top_margin=”20″ bottom_margin=”20″]About ION
ION, headquartered in Corona del Mar, California, provides oncology solutions for physician practices and hospitals who need strategic, financial and management expertise. ION’s management team has expertise in assisting physicians to create and sustain integrated oncology groups which can enhance efficiency and optimize utilization while continuing to provide the best patient care. ION provides solutions for transactional services, project development for cancer centers, financing, management services with expertise in operations, billing and collection, accounting, compliance, IT, M&A, physics and dosimetry and other administrative services.
ION’s management team includes Jeffrey Goffman, who was the Founder and former CEO of Oncure Medical Corp., and Grant Ingersoll, who has years of industry experience with Oncure Medical and Vantage Oncology.
ION is a privately held company whose shareholders include a small group of strategic investors.
For more information on ION, please visit our web site at www.ion-llc.com.
[eltdf_separator class_name=”” type=”full-width” position=”center” color=”#666666″ border_style=”dashed” width=”” thickness=”1″ top_margin=”20″ bottom_margin=”20″]Forward-Looking Statements
Statements in this Press Release that are not historical facts constitute “forward-looking statements.” Any statements contained herein which are not historical facts or which contain the words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “should,” and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of ION with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that ION may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting ION’s industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.
